Malignant Respiratory System Neoplasm — Trials

Malignant Respiratory System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

11,125 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,648
Recruiting: 1,431
Ph III recruiting: 179
Growth YoY: +7.9%
Industry share: 37%
Top sponsor: AstraZeneca
Termination share: 34.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,490)

clinicaltrialsPublishedShowing 801–805 of 805 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04379739	Neoadjuvant PD-1 Antibody Plus Apatinib or Chemotherapy for Non-small Cell Lung Cancer	active not recruiting	Phase 2	89	Shanghai Pulmonary Hospital, Shanghai, ChinaOTHER	1	Dec 6, 2023	clinicaltrials
NCT05811169	Quest for Tumour Evolution of Non-small Cell Lung Cancer	active not recruiting	—	60	The University of Hong KongOTHER	1	Apr 13, 2023	clinicaltrials